{
  "context": {
    "rules": [
      "Rule1: If the potential of Drug X was identified, then the safety of Drug X was confirmed.",
      "Rule2: Provided that the potential of Drug X was identified, phase one of Drug X was completed.",
      "Rule3: Under the condition that phase one of Drug X was completed, Drug X entered phase two.",
      "Rule4: Whenever Drug X received regulatory approval, Drug X was launched commercially.",
      "Rule5: Either Drug X received regulatory approval or, if Drug X entered phase two, then the safety of Drug X was not confirmed.",
      "Rule6: Drug X partnered with a pharma company or Drug X was not launched commercially.",
      "Rule7: If the research team submitted an application, then, should the FDA not be a government agency, Drug X was approved for human trial.",
      "Rule8: Provided that the research team awaited review, then, in the event that the FDA is not a government agency, Drug X was approved for human trial.",
      "Rule9: Under the condition that the research team compiled data, the research team submitted an application.",
      "Rule10: Either the research team compiled data or the research team prepared documents.",
      "Rule11: If the results of Study A were published in Journal B, then Drug X was not tested successfully.",
      "Rule12: Provided that the research team prepared documents, the research team finalized a report.",
      "Rule13: Under the condition that the research team finalized a report, the research team sent a package.",
      "Rule14: Whenever the research team sent a package, the research team awaited review.",
      "Rule15: If the research team received funding, then either the findings of Study A were presented at Conference C or the results of Study A were published in Journal B.",
      "Rule16: Provided that the toxicity of Drug X was analyzed using Material E, animal testing of Drug X was conducted on Species D.",
      "Rule17: If research on Drug X was continued, then the development of Drug X was not halted.",
      "Rule18: If it is not the case that, if it is not the case that, if the FDA is not a government agency then Drug X was approved for human trial, then the toxicity of Drug X was analyzed using Material E, then the development of Drug X was halted.",
      "Rule19: Under the condition that it is not the case that, if it is not the case that, if the FDA is not a government agency then Drug X was approved for human trial, then the toxicity of Drug X was analyzed using Material E, research on Drug X was continued.",
      "Rule20: Under the condition that it is not the case that, if the FDA is not a government agency then Drug X was approved for human trial, it is not the case that animal testing of Drug X was conducted on Species D.",
      "Rule21: Whenever the FDA is not a government agency, Drug X was tested successfully.",
      "Rule22: Provided that the FDA is not a government agency, the potential of Drug X was identified."
    ],
    "facts": [
      "Fact1: The research team received funding.",
      "Fact2: A partnership with a pharmaceutical company for Drug X does not hold.",
      "Fact3: The findings of Study A were not presented at Conference C.",
      "Fact4: Drug X was not approved for human trial."
    ]
  },
  "question": "The FDA is a government agency."
}